Natalia A. Ignatenko

1.7k total citations
47 papers, 1.2k citations indexed

About

Natalia A. Ignatenko is a scholar working on Molecular Biology, Biochemistry and Oncology. According to data from OpenAlex, Natalia A. Ignatenko has authored 47 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 14 papers in Biochemistry and 10 papers in Oncology. Recurrent topics in Natalia A. Ignatenko's work include Polyamine Metabolism and Applications (18 papers), Amino Acid Enzymes and Metabolism (14 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers). Natalia A. Ignatenko is often cited by papers focused on Polyamine Metabolism and Applications (18 papers), Amino Acid Enzymes and Metabolism (14 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers). Natalia A. Ignatenko collaborates with scholars based in United States, France and United Kingdom. Natalia A. Ignatenko's co-authors include Eugene W. Gerner, David E. Stringer, Robert A. Casero, Naveen Babbar, David G. Besselsen, Karen Blohm‐Mangone, Rebecca S. Henkhaus, Hana Holubec, Upal Kunal Basu Roy and Haiyan Cui and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Natalia A. Ignatenko

46 papers receiving 1.2k citations

Peers

Natalia A. Ignatenko
Urs Regenass Switzerland
Edward K. Han United States
Weihe Zhang United States
Paul S. Jones United Kingdom
Frida Ponthan United Kingdom
George W. Small United States
Urs Regenass Switzerland
Natalia A. Ignatenko
Citations per year, relative to Natalia A. Ignatenko Natalia A. Ignatenko (= 1×) peers Urs Regenass

Countries citing papers authored by Natalia A. Ignatenko

Since Specialization
Citations

This map shows the geographic impact of Natalia A. Ignatenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalia A. Ignatenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalia A. Ignatenko more than expected).

Fields of papers citing papers by Natalia A. Ignatenko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalia A. Ignatenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalia A. Ignatenko. The network helps show where Natalia A. Ignatenko may publish in the future.

Co-authorship network of co-authors of Natalia A. Ignatenko

This figure shows the co-authorship network connecting the top 25 collaborators of Natalia A. Ignatenko. A scholar is included among the top collaborators of Natalia A. Ignatenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalia A. Ignatenko. Natalia A. Ignatenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ignatenko, Natalia A., et al.. (2025). Clinical Guidelines for Canine Transmissible Venereal Tumour Treatment: Systematic Review and Meta‐Analysis. Veterinary and Comparative Oncology. 23(2). 125–140. 1 indexed citations
2.
Οικονομοπούλου, Κατερίνα, Antoninus Soosaipillai, Francine Walker, et al.. (2022). Kallikrein-Related Peptidase 6 (KLK6) as a Contributor toward an Aggressive Cancer Cell Phenotype: A Potential Role in Colon Cancer Peritoneal Metastasis. Biomolecules. 12(7). 1003–1003. 10 indexed citations
3.
Pandey, Ritu, Edward R. Abril, Chiu‐Hsieh Hsu, et al.. (2019). Kallikrein 6 protease advances colon tumorigenesis via induction of the high mobility group A2 protein. Oncotarget. 10(58). 6062–6078. 14 indexed citations
4.
Chen, Hao, Chiu‐Hsieh Hsu, Edward R. Abril, et al.. (2017). Does Mutated K-RAS Oncogene Attenuate the Effect of Sulindac in Colon Cancer Chemoprevention?. Cancer Prevention Research. 11(1). 16–26. 4 indexed citations
5.
Sinharay, Sanhita, Edward A. Randtke, Christine M. Howison, Natalia A. Ignatenko, & Mark D. Pagel. (2017). Detection of Enzyme Activity and Inhibition during Studies in Solution, In Vitro and In Vivo with CatalyCEST MRI. Molecular Imaging and Biology. 20(2). 240–248. 26 indexed citations
6.
Ignatenko, Natalia A. & Eugene W. Gerner. (2013). Get the Fat Out!. Cancer Prevention Research. 6(3). 161–164. 3 indexed citations
7.
Ignatenko, Natalia A., et al.. (2011). Polyamines in cancer. Advances in clinical chemistry. 54. 45–70. 28 indexed citations
8.
Zell, Jason A., Argyrios Ziogas, Natalia A. Ignatenko, et al.. (2009). Associations of a Polymorphism in the Ornithine Decarboxylase Gene with Colorectal Cancer Survival. Clinical Cancer Research. 15(19). 6208–6216. 31 indexed citations
9.
Roy, Upal Kunal Basu, et al.. (2008). Wild‐type APC regulates caveolin‐1 expression in human colon adenocarcinoma cell lines via FOXO1a and C‐myc. Molecular Carcinogenesis. 47(12). 947–955. 27 indexed citations
10.
Henkhaus, Rebecca S., Upal Kunal Basu Roy, Dora Cavallo‐Medved, et al.. (2008). Caveolin-1-Mediated Expression and Secretion of Kallikrein 6 in Colon Cancer Cells. Neoplasia. 10(2). 140–148. 44 indexed citations
11.
Bernstein, Harris, Hana Holubec, Carol Bernstein, et al.. (2007). Deoxycholate-Induced Colitis is Markedly Attenuated in Nos2 Knockout Mice in Association with Modulation of Gene Expression Profiles. Digestive Diseases and Sciences. 52(3). 628–642. 23 indexed citations
12.
Hariri, Lida P., Alexandre R. Tumlinson, David G. Besselsen, et al.. (2007). Serial endoscopy in azoxymethane treated mice using ultra-high-resolution optical coherence tomography. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 6432. 643208–643208. 1 indexed citations
13.
Zell, Jason A., Natalia A. Ignatenko, Hagit Yerushalmi, et al.. (2006). Risk and risk reduction involving arginine intake and meat consumption in colorectal tumorigenesis and survival. International Journal of Cancer. 120(3). 459–468. 50 indexed citations
14.
Bernstein, Harris, Hana Holubec, Carol Bernstein, et al.. (2006). Unique dietary-related mouse model of colitis. Inflammatory Bowel Diseases. 12(4). 278–293. 37 indexed citations
15.
Ignatenko, Natalia A., Hana Holubec, David G. Besselsen, et al.. (2006). Role of c-Myc in intestinal tumorigenesis of the Apc min/+ mouse1. Cancer Biology & Therapy. 5(12). 1658–1664. 40 indexed citations
16.
Yerushalmi, Hagit, David G. Besselsen, Natalia A. Ignatenko, et al.. (2005). The role of NO synthases in arginine-dependent small intestinal and colonic carcinogenesis. Molecular Carcinogenesis. 45(2). 93–105. 33 indexed citations
17.
Ignatenko, Natalia A., et al.. (2004). Suppression of polyamine catabolism by activated Ki‐ras in human colon cancer cells. Molecular Carcinogenesis. 39(2). 91–102. 58 indexed citations
18.
Ignatenko, Natalia A., et al.. (2004). The chemopreventive agent α‐difluoromethylornithine blocks Ki‐ras–dependent tumor formation and specific gene expression in Caco‐2 cells. Molecular Carcinogenesis. 39(4). 221–233. 41 indexed citations
19.
Gerner, Eugene W., Natalia A. Ignatenko, & David G. Besselsen. (2003). Preclinical Models for Chemoprevention of Colon Cancer. Recent results in cancer research. 163. 58–71. 7 indexed citations
20.
Ignatenko, Natalia A. & Eugene W. Gerner. (1996). Growth arrest- and polyamine-dependent expression of spermidine/spermine N1-acetyltransferase in human tumor cells.. PubMed. 7(4). 481–6. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026